Drug Dosing: Infants and Children
Pulmonary Hypertension: Classification and Pathogenesis
Asthma: Pathogenesis and Management
Cystic Fibrosis: Pathogenesis
COPD: Pathogenesis and Clinical Features
Case Studies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 29, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Jennifer M Ritchie1, Haopeng Rui, Roderick T Bronson
1Channing Laboratory, Brigham and Women’s Hospital, Boston, Massachusetts, USA.
Researchers developed a new, non-surgical animal model using infant rabbits to study the severe diarrheal disease cholera. By giving the bacteria orally to young rabbits treated with a stomach-acid reducer, they successfully replicated the symptoms and biological features seen in human patients. This model helps scientists investigate how the bacteria interact with the gut and test new vaccines.
Area of Science:
Background:
No reliable, non-surgical animal model for studying the severe diarrheal disease cholera has existed for researchers to use. Previous attempts to replicate human infection often required invasive procedures that failed to mimic natural disease progression. This gap motivated scientists to seek a more accurate, accessible system for observing bacterial behavior. It was already known that Vibrio cholerae causes significant fluid loss in human hosts. However, the specific mechanisms governing how these pathogens colonize the gut remained poorly understood. That uncertainty drove the need for a model that mirrors the clinical presentation of patients. Prior research has shown that animal systems are vital for testing potential medical interventions. No prior work had resolved the challenge of creating a consistent, lethal infection model without surgical intervention.
Purpose Of The Study:
The aim of this study was to establish a reproducible, non-surgical animal model for investigating cholera pathogenesis. Researchers sought to overcome the lack of suitable systems for studying the disease in vivo. They focused on developing a method that mimics the clinical presentation observed in human patients. The team hypothesized that infant rabbits could serve as an effective host for these investigations. They intended to characterize the role of specific bacterial factors in the infection process. By refining the inoculation procedure, they hoped to achieve consistent disease outcomes. This effort was motivated by the need for better tools to analyze bacterial survival and transmission. The study also aimed to assess the utility of this model for testing potential vaccine candidates.
Main Methods:
The review approach involved evaluating a novel, non-surgical animal system for replicating human diarrheal disease. Investigators administered the pathogen orally to 3-day-old rabbits that had received prior cimetidine treatment. This design aimed to bypass the limitations of previous invasive surgical techniques. The team monitored the animals for the development of lethal, watery diarrhea. They compared the physical and chemical properties of the resulting fluid to samples from human patients. Microscopic analysis allowed the researchers to observe bacterial localization within the intestinal tract. The group tested specific bacterial mutants to determine the role of known virulence factors. This systematic evaluation ensured the model accurately reflected clinical disease characteristics.
Main Results:
The strongest finding indicates that orogastric inoculation of the bacteria into pretreated infant rabbits consistently produces lethal, watery diarrhea in virtually all subjects. The diarrheal fluid produced by these animals closely resembles the rice-water stool seen in human patients. Microscopic examination revealed that the bacteria form large aggregates embedded within mucin. These bacterial clusters were found attached to the intestinal epithelium and floating in the fluid. The researchers observed that cholera toxin triggers extensive exocytosis of mucin from goblet cells. Mutant bacteria lacking cholera toxin or toxin-coregulated pilus failed to induce any cholera-like disease. The study demonstrates that the pathogen remains in close association with mucin throughout the infection process. These results confirm that the infant rabbit model successfully replicates key features of human cholera pathogenesis.
Conclusions:
The authors propose that their infant rabbit model provides a reliable platform for investigating cholera infection dynamics. This system allows for the detailed analysis of bacterial survival and transmission factors. Researchers suggest that cholera toxin plays a key role in stimulating mucin release from intestinal cells. The study indicates that this mucin secretion helps the bacteria associate with the host gut. Findings imply that the model is suitable for evaluating the reactogenicity of live attenuated vaccines. The team concludes that the rabbit model effectively mimics the rice-water stool characteristics observed in humans. This work offers a pathway to identify new targets for preventing or treating the disease. The authors believe their approach will facilitate future studies on the interaction between pathogens and host intestinal environments.
The researchers propose that orogastric inoculation of the bacteria into 3-day-old rabbits, following cimetidine pretreatment, triggers lethal, watery diarrhea. This outcome mimics the rice-water stool observed in human patients, providing a reproducible, non-surgical platform for investigating the disease.
The scientists utilize cimetidine, a medication that reduces stomach acid, to ensure the survival and successful colonization of the bacteria. This pretreatment is necessary to achieve consistent, lethal infection in the young animals, which otherwise might not develop the full disease profile.
The authors observe that cholera toxin stimulates extensive exocytosis of mucin from intestinal goblet cells. This process creates an environment where the bacteria form large aggregates, facilitating their attachment to the epithelium and their subsequent exit from the intestinal tract.
The team identifies that mutants lacking cholera toxin and toxin-coregulated pilus fail to induce disease. This finding confirms that these specific virulence factors are required for the pathogen to cause the characteristic, severe diarrheal symptoms observed in the rabbit model.
The study measures the chemical composition and physical appearance of the diarrheal fluid produced by the rabbits. These observations confirm that the rabbit-derived fluid is comparable to the rice-water stool typically found in human cholera patients.
The researchers propose that this model will be useful for testing the reactogenicity of live attenuated vaccines. By providing a consistent system, the authors believe it will help identify factors governing infection, survival, and transmission of the pathogen.